MedTrace Logo

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

NCT07063056 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-08-01

No results posted yet for this study

Summary

Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.

Conditions

  • Triglycerides

Interventions

DIETARY_SUPPLEMENT

Curcumin (Longvida™)

1 capsule per day at a usual curcumin dose for this particular product (80 mg curcumin)

DIETARY_SUPPLEMENT

Half Dose Curcumin (Longvida™)

1 capsule per day at half the usual curcumin dose for this particular product (40 mg curcumin as the half dose)

DIETARY_SUPPLEMENT

Astaxanthin

1 capsule per day at a usual astaxanthin dose (12 mg)

OTHER

Placebo Control

Subject will get 1 capsule per day of a small amount of cellulose

Sponsors & Collaborators

  • Medinutra LLC

    lead OTHER

Principal Investigators

  • Robert DiSilvestro, Ph.D. · Medinutra LLC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-18
Primary Completion
2025-11-15
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07063056 on ClinicalTrials.gov